written by reader The 60 minute cancel treatment

By daveandmelinda, November 15, 2017

Dave Lashmet’s new cancer breakthrough procedure using adaptive radiotherapy is quite interesting. Does anyone know which company he is teasing with this pitch?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

9 Comments
Inline Feedbacks
View all comments
👍 8
JohnM
2 years ago

Looks to me like Accuray (ARAY).

This post is for information sharing only for your own due diligence process and is not intended and should in no way be construed as investment advice. It represents my personal observation and opinion only and my posts are covered under the SGS disclaimer and the disclaimer on the Dr. KSS dropbox. Biotech investing is high risk.

Add a Topic
15
Add a Topic
5916
Add a Topic
3932
Bernard
Bernard
2 years ago

They touted in their promotion that the company had $1B or more is sales, so probably not ARAY

bearbear
bearbear
2 years ago

Check out VRAY instead. I think it is a closer bet. Stock spikes 12% today after yesterday’s webinar. Suspect this is the stock. There is also a report on the stock from Motley Fool on 3rd Nov 2017 that explains a spike of 17% then. The stock has recorded a good ride this year since hitting a low of below $3!

Add a Topic
5971
Add a Topic
5971
Add a Topic
5971
bearbear
bearbear
2 years ago
Reply to  bearbear

Check this interview by VRAY CEO: https://stocknewsnow.com/showcommentary.php?newsartid=ANEWSID15122015100001&title=SNNLive-Video-Interview-with-ViewRay-Inc
Very sure it is VRAY now, shares raise 17% today. The company holds the patents for MRI cum radiotherapy system. Check the company website, very interesting. 4 systems sold and a backlog of about 28 machines and counting. Cost price is approximately $60M/system. System is FDA approved. Only problem is they also have Europe CE Mark, but thought this is pending according to the advertisement?

Add a Topic
5012
Add a Topic
3022
Bobbi
Bobbi
2 years ago
Reply to  bearbear

VRAY’s sales aren’t even close to $1B.

paladin
paladin
2 years ago

Moderator mentioned help in buying stock on foreign markets with subscription. Also stated major breakthrough results just published in last couple of days. Checked JAMA and NE and found nothing.

Add a Topic
5971
👍 2
Bobbi
Bobbi
2 years ago

Found this:
http://medicalphysicsweb.org/cws/article/research/70464
Swedish company, article published 11/15, with link to original article which mentions four patients. http://iopscience.iop.org/article/10.1088/1361-6560/aa9517
However, the moderator talked about 100% with the first four patients treated; the article doesn’t talk about patient outcomes, but proof-of-concept.

👍 1991

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info